Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
193.44
Dollar change
-2.61
Percentage change
-1.33
%
IndexS&P 500 P/E25.79 EPS (ttm)7.50 Insider Own0.85% Shs Outstand181.50M Perf Week-7.06%
Market Cap35.11B Forward P/E14.60 EPS next Y13.25 Insider Trans-0.00% Shs Float179.95M Perf Month-1.36%
Income1.37B PEG2.69 EPS next Q2.64 Inst Own89.83% Short Float1.63% Perf Quarter-9.43%
Sales15.40B P/S2.28 EPS this Y6.81% Inst Trans1.33% Short Ratio1.88 Perf Half Y-18.11%
Book/sh34.45 P/B5.61 EPS next Y11.48% ROA5.13% Short Interest2.93M Perf Year-10.14%
Cash/sh10.15 P/C19.05 EPS next 5Y9.58% ROE22.55% 52W Range187.62 - 261.73 Perf YTD-1.56%
Dividend Est.- P/FCF16.61 EPS past 5Y50.91% ROI7.20% 52W High-26.09% Beta1.50
Dividend TTM- Quick Ratio0.81 Sales past 5Y7.04% Gross Margin27.66% 52W Low3.10% ATR (14)5.90
Dividend Ex-Date- Current Ratio0.84 EPS Y/Y TTM2.46% Oper. Margin14.73% RSI (14)38.83 Volatility2.55% 2.60%
Employees87000 Debt/Eq2.33 Sales Y/Y TTM2.95% Profit Margin8.91% Recom1.52 Target Price245.95
Option/ShortYes / Yes LT Debt/Eq2.14 EPS Q/Q-4.90% Payout0.00% Rel Volume0.98 Prev Close196.05
Sales Surprise0.78% EPS Surprise0.35% Sales Q/Q2.35% EarningsFeb 06 BMO Avg Volume1.56M Price193.44
SMA20-4.43% SMA50-3.56% SMA200-12.05% Trades Volume1,527,451 Change-1.33%
Date Action Analyst Rating Change Price Target Change
Feb-03-25Downgrade BTIG Research Buy → Neutral
Dec-20-24Initiated Stephens Overweight $250
Oct-14-24Initiated Redburn Atlantic Buy
Sep-04-24Initiated RBC Capital Mkts Outperform $275
Jul-24-24Downgrade Jefferies Buy → Hold $266 → $242
Jun-06-24Initiated Goldman Buy $270
Feb-26-24Initiated Leerink Partners Outperform $290
Feb-15-24Downgrade Guggenheim Buy → Neutral
Feb-13-24Initiated BTIG Research Buy $285
Nov-02-23Downgrade Robert W. Baird Outperform → Neutral $248 → $202
Today 09:15AM
Feb-12-25 08:03AM
Feb-07-25 03:36PM
02:15AM
02:08AM
09:30AM Loading…
Feb-06-25 09:30AM
08:10AM
08:08AM
07:17AM
07:00AM
Feb-05-25 08:10AM
Feb-04-25 11:00AM
09:40AM
Feb-03-25 09:50AM
09:16AM
03:55AM Loading…
Jan-30-25 03:55AM
Jan-21-25 04:15PM
Jan-17-25 09:50AM
Jan-16-25 09:40AM
Jan-15-25 12:10PM
10:34AM
Jan-13-25 02:12PM
09:00AM
09:00AM
Dec-23-24 10:19AM
08:00AM
Dec-14-24 09:00PM
Dec-04-24 10:55AM
Dec-03-24 12:41AM
Nov-06-24 04:15PM
07:11AM Loading…
Nov-05-24 07:11AM
Nov-04-24 09:15AM
Nov-01-24 02:27PM
03:10AM
01:04AM
12:45AM
Oct-31-24 08:30PM
08:15AM
07:13AM
07:00AM
Oct-30-24 09:42AM
Oct-28-24 09:16AM
Oct-24-24 10:01AM
Oct-15-24 04:15PM
Oct-04-24 09:40AM
Oct-02-24 09:00AM
Sep-25-24 06:20PM
08:26AM
Sep-19-24 09:00AM
Sep-17-24 09:40AM
01:12AM
Sep-13-24 01:41PM
Sep-12-24 09:50AM
Sep-04-24 02:23PM
09:00AM
Aug-29-24 06:24PM
Aug-21-24 04:15PM
11:30AM
Aug-16-24 10:09AM
Aug-14-24 09:45AM
Jul-31-24 04:13PM
Jul-29-24 09:15AM
Jul-25-24 06:18PM
Jul-24-24 03:26AM
Jul-23-24 09:40AM
01:49AM
01:00AM
Jul-22-24 06:30PM
04:28PM
01:47PM
11:25AM
10:37AM
08:15AM
07:11AM
07:00AM
Jul-17-24 11:00AM
Jul-16-24 06:28PM
Jul-12-24 06:02AM
Jul-11-24 08:30AM
Jul-08-24 04:15PM
Jul-01-24 08:01AM
Jun-25-24 08:00AM
Jun-18-24 08:49AM
06:13AM
Jun-13-24 12:23PM
04:32AM
Jun-12-24 08:00AM
Jun-10-24 08:00AM
Jun-06-24 03:07PM
Jun-03-24 06:28PM
May-28-24 06:04AM
May-24-24 11:17AM
May-14-24 08:00AM
May-09-24 04:15PM
May-07-24 06:49AM
May-04-24 09:27AM
May-03-24 12:11PM
11:49AM
11:17AM
11:00AM
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOUSBIB ARISee RemarksFeb 10 '25Option Exercise65.1640,0002,606,400837,083Feb 12 05:11 PM
DANHAKL JOHN GDirectorDec 03 '24Buy200.581,275255,7401,275Feb 07 07:03 PM
Sherbet EricSee RemarksAug 27 '24Sale246.331,300320,22919,536Aug 29 05:02 PM
Sherbet EricOfficerAug 27 '24Proposed Sale246.331,300320,229Aug 27 05:23 PM
BOUSBIB ARISee RemarksMar 01 '24Option Exercise65.1642,8472,791,911828,430Mar 04 05:28 PM
BOUSBIB ARISee RemarksMar 01 '24Sale250.5331,6787,936,193796,752Mar 04 05:28 PM
STAUB W RICHARDSee RemarksFeb 29 '24Sale247.8014,1003,494,03415,945Mar 04 05:27 PM
Knightly Kevin CSee RemarksFeb 28 '24Option Exercise87.4013,2061,154,21113,858Mar 01 05:07 PM
Knightly Kevin CSee RemarksFeb 28 '24Sale250.178,6072,153,1765,251Mar 01 05:07 PM
Sherbet EricSee RemarksFeb 16 '24Sale241.501,000241,50020,836Feb 21 05:08 PM
Knightly Kevin CSee RemarksFeb 16 '24Option Exercise78.2112,149950,17318,061Feb 21 05:07 PM
Knightly Kevin CSee RemarksFeb 16 '24Sale241.1013,4683,247,165652Feb 21 05:07 PM